CDRE

Analyst Note: Cadre Holdings, Inc. (CDRE)

Date: 2026-06-13 Current Price: $28.25

1. Structural Readiness

• Extension: Not applicable (Price is at the base, not extended).
• ATR Context: Current ATR is 5.4% (High). This falls within the historical "sweet spot" (4–6%) for structural quality, suggesting sufficient volatility to support a move without being in the "extreme" (>8%) danger zone for severe losers.

2. Thesis Layer

• Primary Secular Thesis: Defense Modernization → Legacy Primes (Tier 2).
• Role & Directness: Cadre Holdings acts as a critical Tier 2 supplier and integrator within the defense ecosystem. The company is a direct beneficiary of the "Defense Modernization" wave, specifically through its "Protective Solutions" and "Blast Attenuation" segments.
• Evidence of Exposure: The company secured a key 7-year contract with General Dynamics, European Land Systems ($87M increase in backlog), directly tied to increased European defense spending. Furthermore, the nuclear safety segment is positioned to capture demand from the Department of Energy's mandate to increase plutonium pit production to 80 per year by 2030.
• Additional Tailwinds:
• Law Enforcement Modernization: Driven by a 70% increase in active shooter incidents (2020–2024), creating recurring demand for upgraded body armor and tactical gear.
• Nuclear Remediation: Global prioritization of environmental remediation and nuclear cleanup initiatives supports the "Protective Solutions" division.

3. Business Overview

Cadre Holdings, Inc. is a global leader in manufacturing and distributing safety equipment for law enforcement, first responders, the military, and nuclear markets. The business operates through two distinct segments:

• Products Segment: Proprietary manufacturing under brands like Safariland and Protech Tactical.
• Distribution Arm: Distribution of third-party products (uniforms, optics, footwear, firearms).

Key Operational Metrics (as of Q1 2026):

• Backlog: Ended Q1 2026 with a record backlog of $355 million, including an $108 million organic increase from Q4 2025.
• Recent M&A Integration:
• TYR Tactical: Acquired Jan 30, 2026. Revenue contribution for the three months ended March 31, 2026, was $15.479 million.
• Alien Gear Holsters: Acquired April 2026 via bankruptcy auction for $10.3 million cash.
• Contract Milestones: Secured an $87 million increase from a blast attenuation seat contract with General Dynamics (7-year term).
• Guidance (Management Expectations): Management expects 2026 net sales between $736 million and $758 million and adjusted EBITDA between $136 million and $141 million, implying margins of 18.5%. This represents a 20%+ growth trajectory for net sales and EBITDA.

4. Archetype and Conviction

• Archetype: Deep Value Recovery transitioning into Growth Leader.
• The company is executing a "buy-and-build" strategy (TYR, Alien Gear) to expand its product mix and capture market share in high-growth niches (tactical gear, nuclear safety).
• The "Deep Value" aspect is supported by the record backlog and the re-rating of the business from a pure distributor to a high-margin manufacturer/integrator.
• Valuation Context:
• Forward consensus EPS for FY1 is $1.142 and FY2 is $1.458.
• At a current price of $28.25, the stock trades at approximately 24.7x FY1 EPS and 19.4x FY2 EPS.
• Given the 20%+ growth guidance and the strategic importance of the defense/nuclear backlog, the valuation appears to be pricing in a successful execution of the growth thesis, though not yet at a "deep value" discount.
• Conviction Stack:
• Thesis Strength: High. The secular tailwinds (Defense, Nuclear, Law Enforcement) are structural and backed by government mandates (DoE, DoD).
• Evidence Quality: Strong. Record backlog, specific contract values, and clear M&A integration data provide a solid foundation.
• Rerating Potential: Significant. If the company sustains the 18.5% EBITDA margin and delivers on the 20% growth guidance, the multiple could expand as the market recognizes the shift from a cyclical distributor to a high-growth defense integrator.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• Management guidance cuts for 2026 (specifically if the 20% growth target is missed).
• Failure to integrate the acquired assets (TYR, Alien Gear) without diluting margins.
• What Would Strengthen:
• Announcement of additional large-scale government contracts (e.g., new DoD IDIQ awards).
• Confirmation of the contingent consideration targets for TYR being met early.
• Gaps in Evidence:
• Integration Costs: While revenue from TYR is known, the specific impact of acquisition costs and integration expenses on the 2026 EBITDA margin is not detailed in the provided excerpts.
• Customer Concentration: While E19 states no single customer is >10%, the specific revenue split between the new acquisitions and legacy business is not fully broken out beyond the TYR $15.4M figure.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record $355M backlog with $108M organic growth; 20%+ growth guidance for 2026 net sales and EBITDA; $87M new 7-year contract with General Dynamics. Key risks: Integration execution risk from recent M&A (TYR, Alien Gear); potential margin compression if acquisition costs exceed expectations; geopolitical shifts affecting defense spending. Expected path: Management expects sustained demand from defense and nuclear sectors; the company is positioned to deliver 18.5% EBITDA margins as it integrates new product lines and leverages its expanded backlog. Expected horizon: 6 to 12 months for the thesis to fully play out as the 2026 guidance is delivered and the breakout structure confirms.